HAYWARD, CA--(Marketwire - August 26, 2009) -
Biolog, Inc. announced today record sales for
its fiscal year ending June 30. It closed the year with a record sales
month in June and a record fourth quarter. This growth was
accomplished in spite of the worldwide economic downturn, which also
affected Biolog's customer base.
"We are very proud of our results over the last year," said Barry Bochner,
Ph.D., Biolog's CEO and CSO. "I attribute our strong year during these
challenging economic times to three factors. First, our company has a
unique technology base and product line as the leading company in
phenotypic testing of cells. Even in a year when budgets were tight,
scientists wanted to purchase our GEN III Microbial Identification
System™ and our Phenotype MicroArray (PM) Systems™. Second, our
sales are diversified internationally. Biolog has customers in over 60
countries and this diversification is especially important during economic
downturns. Third, I would cite the improved performance of Biolog's sales
and marketing team."
Biolog's GEN III System is built around a single test panel that can
identify both Gram-negative and Gram-positive bacteria without a Gram
stain. Biolog is the only company to make this breakthrough in
simplification, which saves customers time and money. Furthermore, the
GEN III System is more accurate, as it can identify 1,044 species whereas
other competing systems identify only about 300.
Biolog's revolutionary PM Systems allow testing of thousands of phenotypes
across a wide range of cell types, from microbial to human cells.
Adoption of this technology continues to grow as additional applications
are developed. More than 200 scientific publications and presentations
document the important and unique impact this technology is having on many
aspects of biological research and development.
Along with record sales, which grew by 16%, Biolog also reported another
profitable year. The company has been profitable in all but a few of its
26 years in operation.
Biolog is a privately held company based in Hayward, CA, that continues to
pioneer in the development of powerful new cell analysis tools for solving
critical problems in biological, pharmaceutical, and biotechnological
research and development. It is the world leader in cell phenotyping
technology. Biolog's redox-based technology is unique in its broad
applicability to cells -- this includes bacterial cells and fungal cells as
well as animal cells. More than 200 scientific publications and
presentations document the effectiveness and productivity of PM technology.
The PM product line adds to the innovative microbial identification
products offered by the company, such as the new GEN III System. Biolog
products are available worldwide, either directly from the company or
through its extensive network of international distributors. Further
information can be obtained at Biolog's website, www.biolog.com.